First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices

Cardiology
Corstiaan A den UilAlina A Constantinescu

Abstract

Little is known about circulatory support in cardiogenic shock (CS) from other causes than the acute coronary syndrome or after cardiotomy. We evaluated the effects of first-line intra-aortic balloon pump (IABP) support in this subpopulation of CS patients. A retrospective study was performed in 27 patients with CS from end-stage cardiomyopathy supported firstly by IABP in the years 2011-2016. At 24 h, lactate decreased from 3.2 (2.1-6.8) to 1.8 (1.2-2.2) mmol/L (p < 0.001). Eighteen patients (67%) defined as IABP responders were successfully bridged to either recovery (n = 7), left ventricular assist device (n = 5), or heart transplantation (n = 6). IABP failed in 9 patients (non-responders, 33%) who either died (n = 7) or needed support by extracorporeal membrane oxygenation (n = 2). At 24 h of IABP support, urinary output was higher (2,660 [1,835-4,440] vs. 1,200 [649-2,385] mL; p = 0.02) and fluid balance more negative (-1,564 [-2,673 to -1,086] vs. -500 [-930 to +240] mL; p < 0.001) in responders than non-responders. Overall survival at 1 year was 63%. In most patients, first-line support by IABP in end-stage cardiomyopathy is associated with improvement in organ perfusion and clinical stabilisation for at least 24 h allow...Continue Reading

References

Nov 3, 2001·Journal of the American College of Cardiology·J J FergusonE M Ohman
Dec 13, 2005·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Richard A Santa-CruzE Magnus Ohman
Aug 3, 2007·Interactive Cardiovascular and Thoracic Surgery·Ieva NorkieneVytautas Sirvydis
Jun 12, 2009·European Journal of Heart Failure·Ola GjesdalSvein Simonsen
Oct 19, 2010·Journal of the American College of Cardiology·Biswajit KarPranav Loyalka
Dec 26, 2012·Journal of the American College of Cardiology·Jennifer CowgerMark S Slaughter
Jan 4, 2013·The New England Journal of Medicine·Holger ThieleKarl Werdan
Jan 4, 2013·The New England Journal of Medicine·Sushma Rekhraj, Awsan Noman
Sep 10, 2013·Lancet·Holger ThieleUNKNOWN Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators
Nov 1, 2013·The New England Journal of Medicine·Jean-Louis Vincent, Daniel De Backer
Mar 31, 2015·European Journal of Heart Failure·Veli-Pekka HarjolaUNKNOWN GREAT network
Sep 16, 2015·Intensive Care Medicine·A MebazaaJ Januzzi
Nov 2, 2015·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James K KirklinJames B Young
May 28, 2016·European Heart Journal. Acute Cardiovascular Care·Arun KrishnamoorthyManesh R Patel
Oct 25, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Roger D YusenUNKNOWN International Society for Heart and Lung Transplantation
Nov 30, 2016·Revista Española De Cardiología·Piotr PonikowskiPeter van der Meer

❮ Previous
Next ❯

Citations

Jun 13, 2017·Cardiology·Phillip J Habib, Susan M Joseph
Jun 29, 2018·Future Cardiology·Alice Le Huu, Dominique Shum-Tim
May 31, 2019·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Corstiaan A den UilAlina A Constantinescu
Sep 2, 2020·Current Heart Failure Reports·Jesse R KimmanCorstiaan A den Uil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Related Papers

Current Treatment Options in Cardiovascular Medicine
Jessica L BrownJack O'Connell
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Gary M IdelchikBiswajit Kar
Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine
Anil SachdevNeeraj Gupta
© 2022 Meta ULC. All rights reserved